Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Xylanibacter ruminicola - : Amylum {Starch} |
👶
Prevotella-rich enterotype may benefit gut health in finishing pigs fed diet with a high amylose-to-amylopectin ratio. Animal nutrition (Zhongguo xu mu shou yi xue hui) (Anim Nutr ) Vol: 7 Issue 2 Pages: 400-411 Pub: 2021 Jun Epub: 2021 Feb 25 Authors Ren W , Yan H , Yu B , Walsh MC , Yu J , Zheng P , Huang Z , Luo J , Mao X , He J , Yan H , Chen D , Luo Y , Html Article Publication |
| Increases Xylanibacter ruminicola - : Amylum {Starch} |
👶
The Capacity of the Fecal Microbiota From Malawian Infants to Ferment Resistant Starch. Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 1459 Pub: 2019 Epub: 2019 Jun 26 Authors Wang Y , Mortimer EK , Katundu KGH , Kalanga N , Leong LEX , Gopalsamy GL , Christophersen CT , Richard AC , Shivasami A , Abell GCJ , Young GP , Rogers GB , Html Article Publication |
| Increases Xylanibacter ruminicola - : Amylum {Starch} |
👶
Microbiome-Metabolomics Analysis Investigating the Impacts of Dietary Starch Types on the Composition and Metabolism of Colonic Microbiota in Finishing Pigs. Frontiers in microbiology (Front Microbiol ) Vol: 10 Issue Pages: 1143 Pub: 2019 Epub: 2019 May 29 Authors Yu M , Li Z , Chen W , Rong T , Wang G , Ma X , Html Article Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
